Literature DB >> 16550412

[Fatal familial insomnia: case presentation and discussion of typical clinical and imaging findings].

A V Thomas1, J C Klein, A Brockhaus-Dumke, W D Heiss, A H Jacobs, H F Petereit.   

Abstract

Fatal familial insomnia (FFI) is a hereditary prion disease caused by a mutation in codon 178 of the prion protein gene PRNP on chromosome 20. It is characterized by disturbed night sleep, resulting in daily vigilance perturbations and a variety of other neurological symptoms. We present the case of a 46-year-old woman deteriorating despite immunosuppressive treatment which was initiated suspecting cerebral vasculitis as the cause of her progressive neurological symptoms. The correct diagnosis was established only post mortem. Based on the case presented here, we discuss typical clinical symptoms and imaging findings. In particular, we outline how modern diagnostic methods such as positron emission tomography with [(15)O]H(2)O and [(18)F]FDG and single photon emission computed tomography can add valuable information to results from conventionally performed imaging techniques and genetic testing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16550412     DOI: 10.1007/s00115-006-2073-3

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  25 in total

1.  Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.

Authors:  K Herholz; E Salmon; D Perani; J C Baron; V Holthoff; L Frölich; P Schönknecht; K Ito; R Mielke; E Kalbe; G Zündorf; X Delbeuck; O Pelati; D Anchisi; F Fazio; N Kerrouche; B Desgranges; F Eustache; B Beuthien-Baumann; C Menzel; J Schröder; T Kato; Y Arahata; M Henze; W D Heiss
Journal:  Neuroimage       Date:  2002-09       Impact factor: 6.556

2.  Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178.

Authors:  R Medori; P Montagna; H J Tritschler; A LeBlanc; P Cortelli; P Tinuper; E Lugaresi; P Gambetti
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

3.  Afferent projections to the mediodorsal and anterior thalamic nuclei in the cat. Anatomical-clinical correlations.

Authors:  J L Velayos; M Oliva; F Alfageme
Journal:  Brain Pathol       Date:  1998-07       Impact factor: 6.508

4.  Sleep-wakefulness, EEG and behavioral studies of chronic cats without the thalamus: the 'athalamic' cat.

Authors:  J Villablanca; M E Salinas-Zeballos
Journal:  Arch Ital Biol       Date:  1972-10       Impact factor: 1.000

5.  Serial positron emission tomographic findings in an atypical presentation of fatal familial insomnia.

Authors:  Karl-Jürgen Bär; Frank Häger; Igor Nenadic; T Opfermann; Michael Brodhun; Ralf F Tauber; Stephan Patt; Walter Schulz-Schaeffer; Dietmar Gottschild; Heinrich Sauer
Journal:  Arch Neurol       Date:  2002-11

6.  Pseudo-hypersomnia and pre-sleep behaviour with bilateral paramedian thalamic lesions.

Authors:  C Guilleminault; M A Quera-Salva; M P Goldberg
Journal:  Brain       Date:  1993-12       Impact factor: 13.501

Review 7.  Familial and sporadic fatal insomnia.

Authors:  Pasquale Montagna; Pierluigi Gambetti; Pietro Cortelli; Elio Lugaresi
Journal:  Lancet Neurol       Date:  2003-03       Impact factor: 44.182

8.  Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene.

Authors:  R Medori; H J Tritschler; A LeBlanc; F Villare; V Manetto; H Y Chen; R Xue; S Leal; P Montagna; P Cortelli
Journal:  N Engl J Med       Date:  1992-02-13       Impact factor: 91.245

9.  Fatal familial insomnia: clinical and pathologic study of five new cases.

Authors:  V Manetto; R Medori; P Cortelli; P Montagna; P Tinuper; A Baruzzi; G Rancurel; J J Hauw; J J Vanderhaeghen; P Mailleux
Journal:  Neurology       Date:  1992-02       Impact factor: 9.910

10.  Beta-CIT SPECT demonstrates reduced availability of serotonin transporters in patients with Fatal Familial Insomnia.

Authors:  S Klöppel; W Pirker; T Brücke; G G Kovács; G Almer
Journal:  J Neural Transm (Vienna)       Date:  2002-07       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.